Kintara Therapeutics Inc [NASDAQ: KTRA] gained 15.70% on the last trading session, reaching $0.19 price per share at the time.
If compared to the average trading volume of 3.10M shares, KTRA reached a trading volume of 68504007 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about Kintara Therapeutics Inc [KTRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for KTRA shares is $14.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on KTRA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Trading performance analysis for KTRA stock
Kintara Therapeutics Inc [KTRA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.66. With this latest performance, KTRA shares dropped by -0.87% in over the last four-week period, additionally plugging by 116.54% over the last 6 months – not to mention a drop of -95.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KTRA stock in for the last two-week period is set at 54.26, with the RSI for the last a single of trading hit 60.19, and the three-weeks RSI is set at 51.17 for Kintara Therapeutics Inc [KTRA]. The present Moving Average for the last 50 days of trading for this stock 0.1967, while it was recorded at 0.1721 for the last single week of trading, and 0.1701 for the last 200 days.
Kintara Therapeutics Inc [KTRA]: A deeper dive into fundamental analysis
Kintara Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.04 and a Current Ratio set at 5.04.
Kintara Therapeutics Inc [KTRA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Kintara Therapeutics Inc posted -3.5/share EPS, while the average EPS was predicted by analysts to be reported at 0/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -3.5. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for KTRA.
An analysis of Institutional ownership at Kintara Therapeutics Inc [KTRA]
There are presently around $1.48%, or 1.48%% of KTRA stock, in the hands of institutional investors.
